Literature DB >> 1371783

Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72).

W Luo1, H Van de Velde, I von Hoegen, J R Parnes, K Thielemans.   

Abstract

CD5 is a 67-kDa glycoprotein expressed on the cell surface membrane of all T lymphocytes and on a small proportion of B lymphocytes. The physiologic role of this Ag is still unknown. Structural and functional studies of CD5 suggest that it might act as a receptor for a positive signal. CD5-specific mAb augment CD3- or mitogen-induced T cell proliferation, IL-2 secretion, and IL-2R expression and induce a rise in intracellular [Ca2+]. In this report, we describe the purification of mouse CD5 protein (mCD5) and its use as a probe to search for the ligand of CD5. We demonstrate that mCD5 specifically interacts with the mouse B cell differentiation Ag CD72/Lyb-2. Three serologically defined allelic forms of mouse CD72/Lyb-2 can all interact with mCD5. We further show that mCD5 can interact with human CD72/Lyb-2, and similarly, that human CD5 can interact with mouse CD72/Lyb-2. These studies may have major implications for the mechanisms of T-B cell communication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371783

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.

Authors:  L Ginaldi; N Farahat; E Matutes; M De Martinis; R Morilla; D Catovsky
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  CD5 monoclonal antibodies react with human peripheral blood dendritic cells.

Authors:  G S Wood; P S Freudenthal
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

5.  B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

Authors:  S Indraccolo; M Mion; R Zamarchi; A Veronesi; M L Veronese; M Panozzo; C Betterle; A Barelli; A Borri; A Amadori
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

6.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

7.  The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.

Authors:  M Raab; M Yamamoto; C E Rudd
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

8.  Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.

Authors:  L Biancone; M A Bowen; A Lim; A Aruffo; G Andres; I Stamenkovic
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

9.  A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.

Authors:  A R Arulanandam; P Moingeon; M F Concino; M A Recny; K Kato; H Yagita; S Koyasu; E L Reinherz
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  Utility of Cluster of Differentiation 5 and Cluster of Differentiation 117 Immunoprofile in Distinguishing Thymic Carcinoma from Pulmonary Squamous Cell Carcinoma: A Study on 1800 Nonsmall Cell Lung Cancer Cases.

Authors:  Vidya Jha; Preeti Sharma; Ashish Kumar Mandal
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.